These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1494 related items for PubMed ID: 9408683

  • 1. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 2. The importance of early cyclosporine levels in pediatric kidney transplantation.
    Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner R, Najarian JS.
    Clin Transplant; 1996 Dec; 10(6 Pt 1):482-6. PubMed ID: 8996767
    [Abstract] [Full Text] [Related]

  • 3. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 4. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 5. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Jul; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 6. Kidney transplantation, the Halifax experience.
    Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B, West K, Sketris I.
    Clin Transpl; 1996 Jul; ():231-40. PubMed ID: 9286572
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 8. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 9. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Jan; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 10. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM.
    Clin Transpl; 1997 Jan; ():1-14. PubMed ID: 9919387
    [Abstract] [Full Text] [Related]

  • 11. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO, Dias MF, Pacheco-Silva A.
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [Abstract] [Full Text] [Related]

  • 12. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 13. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 14. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V, Rice JC, Carson RW, Gugliuzza KK, Fish JC.
    Clin Transplant; 1996 Apr 27; 10(2):203-8. PubMed ID: 8664520
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 16. CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?
    Soin AS, Rasmussen A, Jamieson NV, Watson CJ, Friend PJ, Wight DG, Calne RY.
    Transplantation; 1995 Apr 27; 59(8):1119-23. PubMed ID: 7732557
    [Abstract] [Full Text] [Related]

  • 17. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug 27; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

  • 18. The UNOS renal transplant registry.
    Cecka JM.
    Clin Transpl; 2001 Aug 27; ():1-18. PubMed ID: 12211771
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov 27; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 27; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.